跳至主要内容
临床试验/NCT00190931
NCT00190931已完成4 期

A Double-Blind Study of Functional Outcomes With Atomoxetine-Hydrochloride and Placebo in Adult Outpatients With DSM-IV Attention-Deficit/Hyperactivity Disorder

Eli Lilly and Company1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2003年11月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
400
试验地点
1
主要终点
Test the hypothesis that, compared with placebo, administration of atomoxetine for approximately 6 months will result in an improved work productivity,as measured on the Endicott Work Productivity Scale (EWPS) during Study Period II.

研究概览

简要总结

The overall primary objective of this study is to test the hypothesis that, compared with placebo,administration of atomoxetine will result in an improved work productivity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Meet DSM-IV criteria for Attention-Deficit/Hyperactivity Disorder (ADHD).
  • •Have a CGI-S-ADHD score of 4 (moderate symptoms) or greater at Visit 1 and Visit
  • •Adult Men or Women, 18 years of age or older and not more than 50 years of age at Visit
  • •Laboratory results must show no clinically significant abnormalities.
  • •Paid employees working 20 hours or more per week and who have been paid in their current place of employment for 6 months or more.

排除标准

  • •Meet diagnostic criteria for current major depression, a current anxiety disorder and history of bipolar disorder or any history of a psychotic disorder will be excluded from the study.
  • •Are pregnant or are breastfeeding.
  • •Have organic brain disease. Have a history of any seizure disorder or patients who have taken or are currently taking anticonvulsants for seizure control.
  • •Are taking any psychotropic medication on a regular basis that has central nervous system activity. Must have a washout equal to a minimum of 5 half-lives of that medication prior to Visit
  • •Are unstable in any way to participate in this study, in the opinion of the investigator.

结局指标

主要结局

Test the hypothesis that, compared with placebo, administration of atomoxetine for approximately 6 months will result in an improved work productivity,as measured on the Endicott Work Productivity Scale (EWPS) during Study Period II.

次要结局

  • To assess the efficacy of atomoxetine in treating core symptoms in adults during Study Period II using the Conners'Adult Attention Deficit/Hyperactivity Disorder Rating Scale-Investigator rated.

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验